Sparrow R L, McKenzie I F
Transplantation. 1983 Aug;36(2):166-71. doi: 10.1097/00007890-198308000-00011.
The ability of an antihuman T200 monoclonal antibody, F2.5, to specifically inhibit in vitro human natural killer cell-mediated lysis of K562 target cells is demonstrated. No inhibition by the F2.5 antibody of a cytotoxic T lymphocyte response to autologous virus-infected cells could be shown. Direct binding studies indicated that F2.5 antibody-coated effector cells had a reduced capacity to bind to K562 target cells, suggesting that T200 has a function in the recognition and binding of the natural killer cell to its target cell. This is the first time a role for human T200 and identification of a functional natural killer cell receptor have been described.
已证实抗人T200单克隆抗体F2.5能够特异性抑制体外人自然杀伤细胞介导的对K562靶细胞的裂解。未发现F2.5抗体对细胞毒性T淋巴细胞对自体病毒感染细胞的反应有抑制作用。直接结合研究表明,用F2.5抗体包被的效应细胞与K562靶细胞的结合能力降低,这表明T200在自然杀伤细胞识别和结合其靶细胞中具有一定作用。这是首次描述人T200的作用以及功能性自然杀伤细胞受体的鉴定。